Delivery Order SPE2DX22D0010-SPE2D824FBB07
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,213.22 firm fixed-price delivery order contract is for the supply of CONCERTA ER TABS 27MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,075.43, is for the delivery of CONCERTA ER TABS 36MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,598.56 firm fixed-price delivery order is for the supply of CONCERTA ER TABS 36MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $31,245.94, is for the delivery of CONCERTA ER TABS 36MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm fixed-price delivery order with an ultimate completion date of October 18, 2024. Amerisourcebergen, a...
- This federal contract award, valued at $35,994.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of CONCERTA ER TABS 36MG, a medication used in the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing type and an ultimate completion date of December 4, 2024. Amerisourcebergen holds a larger Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,128.62 firm fixed-price delivery order is for the supply of 100 units of CONCERTA ER 54 MG TABLET, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 15, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,961.18, is for the delivery of Concerta ER Tabs 36mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,329.27 firm fixed-price delivery order is for the supply of CONCERTA ER TABS 36MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,092.04 firm fixed-price delivery order is for CONCERTA ER TABS 36MG, with a period of performance through March 25, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,953.89 firm-fixed-price delivery order is for the supply of CONCERTA ER TABS 36MG, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of June 30, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FBB07Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,208.65 firm fixed-price delivery order is for the supply of CONCERTA ER TABS 36MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC contract. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 10/17/23 |